Experts boost activity of potential therapeutic target in triple-negative breast cancer
Less than 20% of diagnosed breast cancers are designated "triple-negative," lacking three types of receptors often found in other breast cancer types. But TNBCs have a higher risk of recurrence, metastasis and mortality. ...
Nov 30, 2022
0
8